FDAnews Drug Daily Bulletin

BIOSANTE PHARMA FY05 LOSS NARROWS FROM LAST YEAR

April 3, 2006
A A

Biosante Pharmaceuticals Inc. said it incurred a net loss of $9.7 million or $0.50 per share for the year ended December 31, 2005, compared to a net loss of $12 million or $0.70 per share in last year. Trading Markets (http://www.tradingmarkets.com/tm.site/news/BREAKING%20NEWS/208646/)